Trade Report: Today, Amica Retiree Medical Trust decides to keep it stake in Cigna Corp. (CI) to the level of $187,000

Today, Amica Retiree Medical Trust decides to keep it stake in Cigna Corp. (CI) to the level of $187,000

Amica Retiree Medical Trust reduced its stake in Cigna Corp. (NYSE:CI) by 14.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,435 shares of the company’s stock after selling 242 shares during the period. Amica Retiree Medical Trust’s holdings in Cigna Corp. were worth $187,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in CI. A.R.T. Advisors LLC bought a new stake in Cigna Corp. during the first quarter valued at $1,244,000. LPL Financial LLC increased its stake in Cigna Corp. by 26.8% in the first quarter. LPL Financial LLC now owns 33,048 shares of the company’s stock valued at $4,478,000 after buying an additional 6,978 shares in the last quarter. Arizona State Retirement System increased its stake in Cigna Corp. by 0.3% in the first quarter. Arizona State Retirement System now owns 72,974 shares of the company’s stock valued at $10,015,000 after buying an additional 200 shares in the last quarter. Seven Eight Capital LLC bought a new stake in Cigna Corp. during the first quarter valued at $659,000. Finally, Ladenburg Thalmann Financial Services Inc. increased its stake in Cigna Corp. by 69.0% in the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 7,663 shares of the company’s stock valued at $1,052,000 after buying an additional 3,128 shares in the last quarter. 85.29% of the stock is owned by institutional investors and hedge funds.

Shares of Cigna Corp. (NYSE:CI) traded down 0.62% during midday trading on Friday, hitting $138.67. 306,591 shares of the stock were exchanged. The stock has a 50 day moving average price of $127.40 and a 200-day moving average price of $129.17. The company has a market cap of $35.60 billion, a PE ratio of 18.84 and a beta of 0.50. Cigna Corp. has a 12 month low of $115.03 and a 12 month high of $148.99.

Cigna Corp. (NYSE:CI) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $1.94 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.91 by $0.03. The firm earned $9.90 billion during the quarter, compared to analysts’ expectations of $4.37 billion. Cigna Corp. had a net margin of 4.87% and a return on equity of 16.17%. The firm’s quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter last year, the company posted $2.28 EPS. On average, analysts predict that Cigna Corp. will post $7.98 EPS for the current year.

Several analysts have recently weighed in on CI shares. Zacks Investment Research raised shares of Cigna Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, October 4th. Jefferies Group reaffirmed a “buy” rating on shares of Cigna Corp. in a research note on Tuesday, August 23rd. Leerink Swann reaffirmed a “buy” rating and set a $155.00 price target on shares of Cigna Corp. in a research note on Monday, September 26th. William Blair reaffirmed a “buy” rating on shares of Cigna Corp. in a research note on Wednesday, August 31st. Finally, Goldman Sachs Group Inc. reaffirmed a “buy” rating and set a $160.00 price target on shares of Cigna Corp. in a research note on Thursday, September 8th. Six equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $156.00.

In other Cigna Corp. news, EVP John M. Murabito sold 58,822 shares of the stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $125.09, for a total transaction of $7,358,043.98. Following the sale, the executive vice president now directly owns 115,109 shares in the company, valued at approximately $14,398,984.81. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Jason D. Sadler sold 4,000 shares of the stock in a transaction that occurred on Monday, October 31st. The stock was sold at an average price of $121.80, for a total transaction of $487,200.00. Following the sale, the insider now owns 34,019 shares in the company, valued at $4,143,514.20. The disclosure for this sale can be found here. Corporate insiders own 1.20% of the company’s stock.

Cigna Corp. Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

Related posts

Leave a Comment